Literature DB >> 31066029

Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al.

Jifang Zhou1, Jin Han1,2,3, Edith A Nutescu1, William L Galanter2,4, Surrey M Walton1, Victor R Gordeuk3, Santosh L Saraf3, Gregory S Calip1,5.   

Abstract

Entities:  

Keywords:  diabetes; epidemiology; sickle cell disease

Mesh：

Year:  2019        PMID： 31066029      PMCID： PMC6706311          DOI： 10.1111/bjh.15949

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Type 2 diabetes in adults with sickle cell disease: can we dive deeper?

Authors:  Sarah Skinner; Elie Nader; Philippe Connes
Journal:  Br J Haematol       Date:  2019-05-08       Impact factor: 6.998

3.  Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.

Authors:  Jifang Zhou; Jin Han; Edith A Nutescu; William L Galanter; Surrey M Walton; Victor R Gordeuk; Santosh L Saraf; Gregory S Calip
Journal:  Br J Haematol       Date:  2019-02-03       Impact factor: 6.998

4.  Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.

Authors:  S K Ballas
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

5.  Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease.

Authors:  Xu Zhang; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Jin Han; Michel Gowhari; Johara Hassan; Galina Miasnikova; Adelina Sergueeva; Sergei Nekhai; Rick Kittles; Roberto F Machado; Joe G N Garcia; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani; Donald A McClain; Victor R Gordeuk
Journal:  Hum Genet       Date:  2015-05-30       Impact factor: 4.132

6.  Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy.

Authors:  Sheri M Kosecki; Philip T Rodgers; Martha B Adams
Journal:  Ann Pharmacother       Date:  2005-08-02       Impact factor: 3.154

Review 7.  Therapy insight: metabolic and endocrine disorders in sickle cell disease.

Authors:  Dawn Smiley; Samuel Dagogo-Jack; Guillermo Umpierrez
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

8.  Factors associated with survival in a contemporary adult sickle cell disease cohort.

Authors:  Hany Elmariah; Melanie E Garrett; Laura M De Castro; Jude C Jonassaint; Kenneth I Ataga; James R Eckman; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

9.  The accuracy of hospital ICD-9-CM codes for determining Sickle Cell Disease genotype.

Authors:  Angela B Snyder; Peter A Lane; Mei Zhou; Susan T Paulukonis; Mary M Hulihan
Journal:  J Rare Dis Res Treat       Date:  2017-07-28

10.  Survival Probability in Patients with Sickle Cell Anemia Using the Competitive Risk Statistical Model.

Authors:  Emilia Matos do Nascimento; Clarisse Lopes de Castro Lobo; Basilio de Bragança Pereira; Samir K Ballas
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-03-01       Impact factor: 2.576
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.